Share Issue/Capital Change • Mar 30, 2022
Share Issue/Capital Change
Open in ViewerOpens in native device viewer

PRESS RELEASE
Agfa Press Office Septestraat 27 B – 2640 Mortsel Belgium
Johan Jacobs Corporate Press Relations Manager
T +32 3 444 80 15 F +32 3 444 74 85 E [email protected]
Mortsel, Belgium – March 30, 2022 – 5:40 p.m. CET
As a result of the decision of the Board of Directors on March 9, 2021, the company, by notarial deed dated March 30, 2022, cancelled a total of 2,299,218 treasury shares. This decision was taken in accordance with the authorization granted to the Board of Directors by the Extraordinary General Meeting of Shareholders on May 12, 2020.
The new data concerning the company's shares and capital following this transaction is as follows:
| Old number of outstanding shares: | 160,506,706 |
|---|---|
| Number of cancelled shares: | 2,299,218 |
| New number of outstanding shares (denominator): | 158,207,488 |
| Share capital: | 186,794,611.00 Euro |
| Total number of voting rights: | 158,207,488 |
| Total number of voting securities: | 158,207,488 |
| Total number of shares without voting rights: | 0 |
The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds four divisions: Radiology Solutions, HealthCare IT, Digital Print & Chemicals and Offset Solutions. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2021, the Group realized a turnover of 1,760 million Euro.
Contact: Viviane Dictus Director Corporate Communication T +32 (0) 3 444 71 24 E [email protected]
Corporate Press Relations Manager T +32 (0)3/444 80 15 E [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.